The activating receptor NKp46 is essential for the development of type 1 diabetes

被引:145
作者
Gur, Chamutal [1 ,2 ]
Porgador, Angel [3 ,4 ]
Elboim, Moran [1 ]
Gazit, Roi [1 ]
Mizrahi, Saar [1 ]
Stern-Ginossar, Noam [1 ]
Achdout, Hagit [1 ]
Ghadially, Hormas [1 ]
Dor, Yuval
Nir, Tomer
Doviner, Victoria [5 ]
Hershkovitz, Oren [3 ,4 ]
Mendelson, Michal [3 ,4 ]
Naparstek, Yaakov [2 ]
Mandelboim, Ofer [1 ]
机构
[1] Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Gen & Tumor Immunol, Inst Med Res Israel Canada, IL-91010 Jerusalem, Israel
[2] Hadassah Hebrew Univ Hosp, Dept Med, Jerusalem, Israel
[3] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel
[4] Ben Gurion Univ Negev, Shraga Segal Dept Microbiol & Immunol, IL-84105 Beer Sheva, Israel
[5] Hadassah Hebrew Univ Hosp, Dept Pathol, Jerusalem, Israel
基金
以色列科学基金会;
关键词
NATURAL-KILLER-CELL; VIRUS-INFECTED CELLS; NOD MICE; NK CELLS; PANCREATIC-ISLETS; STREPTOZOTOCIN; LYSIS; MODEL; MELLITUS; BETA;
D O I
10.1038/ni.1834
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The mechanism of action of natural killer (NK) cells in type 1 diabetes is still unknown. Here we show that the activating receptor NKp46 recognizes mouse and human ligands on pancreatic beta cells. NK cells appeared in the pancreas when insulitis progressed to type 1 diabetes, and NKp46 engagement by beta cells led to degranulation of NK cells. NKp46-deficient mice had less development of type 1 diabetes induced by injection of a low dose of streptozotocin. Injection of soluble NKp46 proteins into nonobese diabetic mice during the early phase of insulitis and the prediabetic stage prevented the development of type 1 diabetes. Our findings demonstrate that NKp46 is essential for the development of type 1 diabetes and highlight potential new therapeutic modalities for this disease.
引用
收藏
页码:121 / U37
页数:9
相关论文
共 37 条
[11]   Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1 [J].
Gazit, R ;
Gruda, R ;
Elboim, M ;
Arnon, TI ;
Katz, G ;
Achdout, H ;
Hanna, J ;
Qimron, U ;
Landau, G ;
Greenbaum, E ;
Zakay-Rones, Z ;
Porgador, A ;
Mandelboim, O .
NATURE IMMUNOLOGY, 2006, 7 (05) :517-523
[12]   Enhanced In Vivo Growth of Lymphoma Tumors in the Absence of the NK-Activating Receptor NKp46/NCR1 [J].
Halfteck, Gili G. ;
Elboim, Moran ;
Gur, Chamutal ;
Achdout, Hagit ;
Ghadially, Hormas ;
Mandelboim, Ofer .
JOURNAL OF IMMUNOLOGY, 2009, 182 (04) :2221-2230
[13]   HUMAN-FETAL THYMUS AND BONE-MARROW CONTAIN TARGET-CELLS FOR NATURAL-KILLER CELLS [J].
HANSSON, M ;
KIESSLING, R ;
ANDERSSON, B .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1981, 11 (01) :8-12
[14]   Diabetes induced by Coxsackie virus: Initiation by bystander damage and not molecular mimicry [J].
Horwitz, MS ;
Bradley, LM ;
Harbertson, J ;
Krahl, T ;
Lee, J ;
Sarvetnick, N .
NATURE MEDICINE, 1998, 4 (07) :781-785
[15]   TRANSFER OF DIABETES IN MICE PREVENTED BY BLOCKADE OF ADHESION-PROMOTING RECEPTOR ON MACROPHAGES [J].
HUTCHINGS, P ;
ROSEN, H ;
OREILLY, L ;
SIMPSON, E ;
GORDON, S ;
COOKE, A .
NATURE, 1990, 348 (6302) :639-641
[16]   NK cells, MHC class I molecules and the missing self [J].
Kärre, K .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2002, 55 (03) :221-228
[17]   THE MURINE AUTOIMMUNE DIABETES MODEL - NOD AND RELATED STRAINS [J].
KIKUTANI, H ;
MAKINO, S .
ADVANCES IN IMMUNOLOGY, 1992, 51 :285-322
[18]   ISLET CELLS BUT NOT THYROCYTES ARE SUSCEPTIBLE TO LYSIS BY NK CELLS [J].
KITAGAWA, Y ;
GREINER, DL ;
REYNOLDS, CW ;
ORTALDO, JR ;
TOCCAFONDI, R ;
HANDLER, ES ;
VANDERMEIDE, PH ;
MORDES, JP ;
ROSSINI, AA .
JOURNAL OF AUTOIMMUNITY, 1991, 4 (05) :703-716
[19]   STREPTOZOTOCIN-INDUCED PANCREATIC INSULITIS - NEW MODEL OF DIABETES-MELLITUS [J].
LIKE, AA ;
ROSSINI, AA .
SCIENCE, 1976, 193 (4251) :415-417
[20]   NOD mouse model for Sjogren's syndrome: lack of longitudinal stability [J].
Lodde, B. M. ;
Mineshiba, F. ;
Kok, M. R. ;
Wang, J. ;
Zheng, C. ;
Schmidt, M. ;
Cotrim, A. P. ;
Kriete, M. ;
Tak, P. P. ;
Baum, B. J. .
ORAL DISEASES, 2006, 12 (06) :566-572